about
Flavin mononucleotide-based fluorescent proteins function in mammalian cells without oxygen requirementAdvancing Clostridia to Clinical Trial: Past Lessons and Recent ProgressSalmonella enterica serovars Typhimurium and Typhi as model organisms: revealing paradigm of host-pathogen interactionsNovel tools to analyze the function of Salmonella effectors show that SvpB ectopic expression induces cell cycle arrest in tumor cellsMagnetic resonance imaging of tumors colonized with bacterial ferritin-expressing Escherichia coliMolecular imaging of biological gene delivery vehicles for targeted cancer therapy: beyond viral vectors.Tumor-targeted delivery of biologically active TRAIL protein.TransKingdom RNA interference: a bacterial approach to challenges in RNAi therapy and delivery.Gut microbial metabolism and colon cancer: can manipulations of the microbiota be useful in the management of gastrointestinal health?Neoadjuvant administration of Semliki Forest virus expressing interleukin-12 combined with attenuated Salmonella eradicates breast cancer metastasis and achieves long-term survival in immunocompetent mice."Alternative" endocytic mechanisms exploited by pathogens: new avenues for therapeutic delivery?Controlled progressive innate immune stimulation regimen prevents the induction of sickness behavior in the open field test.Salmonella typhimurium mediated delivery of Apoptin in human laryngeal cancer.A genetically enhanced anaerobic bacterium for oncopathic therapy of pancreatic cancerTranskingdom RNA interference (tkRNAi) as a new delivery tool for therapeutic RNA.Microbial-based therapy of cancer: current progress and future prospects.Bacteria as vectors for gene therapy of cancer.Bacteria-mediated disease therapy.A genomic approach to the cryptic secondary metabolome of the anaerobic world.The potential roles of bacteria to improve radiation treatment outcome.Gene therapy approaches against cancer using in vivo and ex vivo gene transfer of interleukin-12.Salmonella-Mediated Cancer Therapy: Roles and Potential.Salmonella-mediated tumor-targeting TRAIL gene therapy significantly suppresses melanoma growth in mouse model.Optical Imaging of Bacterial Infection ModelsColonization of experimental murine breast tumours by Escherichia coli K-12 significantly alters the tumour microenvironment.Selective bacterial patterning using the submerged properties of microbeads on agarose gel.Anaerobe-Inspired Anticancer Nanovesicles.Bifidobacterium breve as a delivery vector of IL-24 gene therapy for head and neck squamous cell carcinoma in vivo.Advances in Stimulus-Responsive Polymeric Materials for Systemic Delivery of Nucleic Acids.Development of bacteria-based microrobot using biocompatible poly(ethylene glycol).Effect of Salmonella treatment on an implanted tumor (CT26) in a mouse model.The Pivotal Role of DNA Repair in Infection Mediated-Inflammation and Cancer.
P2860
Q21134070-A2305BA4-02BC-461A-8F49-AC1ABADF993CQ26745551-4D52C6A9-EDBF-4B7A-BF07-02BD8B48D5D1Q26996526-861DC0FC-EFDF-4AF0-BB74-1DBEA9CBC006Q27303201-BCCBB824-BF39-4E3D-8780-023F517CC1A5Q28744347-0630A09A-633D-4B69-8928-286F98D9B39AQ33704231-BEBFFE2E-EF98-461D-A489-A3FA3F577ED8Q33809123-10464A0C-BD38-4BF3-94A6-648480318CC9Q33848915-527D44C7-3150-42CC-9497-6CC3C3BEC296Q35544903-D26B37F0-9918-414E-85D5-7E89B0255799Q35766493-603A337E-0E4A-40F0-A525-960A662DE157Q36913900-6AF4B2E0-2B89-449C-9A55-01FC0800D1FCQ37089206-05523D34-AAF5-45DC-9424-94617568BB5AQ37249330-BDA9AD8E-77A9-4E69-92DF-8347D5CAFD23Q37288950-AE66B769-B953-485D-AC70-B9114103AD3DQ37600906-641F23C0-9150-4EC8-BEEE-EC8F96BE86F2Q37843621-802C3B13-0F96-43DF-94AC-CDEC2609E92CQ37862087-7FB4E289-D99D-425E-933B-038466838E2EQ37950232-CCE27406-77FB-4D17-B11D-133BDEDECAD8Q38069492-A13C72FB-EC88-4B41-B8F1-5276BE76E7A7Q38670007-41E9DE22-F6FB-4F3C-A081-2D5578021D63Q38703318-0080EF54-0CC4-4D63-A50E-249539C3C817Q39339432-828AAA0C-9F0E-488A-89BE-C97EF7D646B1Q39447947-54718C1D-86F9-4E06-B603-97AE7A4D33BAQ39888990-8C98F7FB-418E-4D6B-9861-08D6D195BC5EQ40022374-A2BCCECA-D85B-44B2-BD70-826142E21441Q44419750-2B707E9B-9086-47F3-8A91-35D6ACF22833Q44869819-AE8601FD-C952-4218-BCDA-D9A3D75CD308Q45870726-31B8AC09-1F6F-47E1-A353-9C10FE8EC116Q46244037-8245AE25-67C9-4157-BA7E-B682FCA6C8AFQ50023169-2B387662-819C-4D5E-AD06-F5DD810C0494Q50025874-311ADA93-4E7A-4DA6-8C4D-0896837C85E9Q55344660-F1080E92-0564-4088-991B-8E706F179C7B
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Use of bacteria in anti-cancer therapies.
@ast
Use of bacteria in anti-cancer therapies.
@en
type
label
Use of bacteria in anti-cancer therapies.
@ast
Use of bacteria in anti-cancer therapies.
@en
prefLabel
Use of bacteria in anti-cancer therapies.
@ast
Use of bacteria in anti-cancer therapies.
@en
P2093
P2860
P356
P1433
P1476
Use of bacteria in anti-cancer therapies.
@en
P2093
Claire E Lewis
Jeffrey Green
Rachel M Ryan
P2860
P356
10.1002/BIES.20336
P407
P577
2006-01-01T00:00:00Z